Biostage to Participate at the WSCS16

Biostage to Participate at the WSCS16

Biostage, Inc. (Nasdaq: BSTG), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, will be presenting at the World Stem Cell Summit / Regmed Capital Conference...